---
title: Prognostic significance of metabolomic biomarkers in patients with diabetes
  mellitus and coronary artery disease
date: '2022-05-07'
linkTitle: https://pubmed.ncbi.nlm.nih.gov/35525960/?utm_source=curl&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1Zkrxt7ktlCbHBXEV3v65xxSnkSWNsJ1A6Fq3gBniKhGfIUslK&fc=20210907212339&ff=20220510212350&v=2.17.6
source: metablomics[MeSH Terms]
description: 'CONCLUSIONS: In patients with comorbid DM and CAD, novel metabolomic
  biomarkers and metabolomics-based prediction models could be recruited to predict
  clinical outcomes and assess the complexity of CAD, thereby enabling the integration
  of personalized medicine into routine clinical practice. These associations should
  be interpreted taking into account the observational nature of this study, and thus,
  larger trials are needed to confirm its results and validate them in different and
  ...'
---
CONCLUSIONS: In patients with comorbid DM and CAD, novel metabolomic biomarkers and metabolomics-based prediction models could be recruited to predict clinical outcomes and assess the complexity of CAD, thereby enabling the integration of personalized medicine into routine clinical practice. These associations should be interpreted taking into account the observational nature of this study, and thus, larger trials are needed to confirm its results and validate them in different and ...